ID: MRFR/PNT/5724-CR | 170 Pages | Author: Snehal Singh | August 2022
Temperature Controlled Packaging for Pharmaceutical Market Size was valued at USD 10.1 billion in 2021. The temperature controlled packaging for pharmaceutical market industry is projected to grow from USD 11.02 Billion in 2022 to USD 20.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.20% during the forecast period (2022 - 2030). Rising prevalence of chronic disease incidents and growing number of clinical trials are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The government's implementation of tight rules and regulations is anticipated to increase the efficiency of how pharmaceutical products are distributed. For instance, the Food & Drug Administration (US), Regulation 21 CFR 211.150 "Distribution procedures," states that pharmaceutical products must be shipped within appropriate temperatures and under accurate conditions in accordance with requirements. In addition, the regulation specifies that appropriate manual, electromechanical, or electronic temperature and humidity recording equipment, devices, and/or logs shall be used to document proper storage of prescription drugs.
Containerized cargo volumes at the Port of Mobile are expected to increase in 2021 as shippers look for uncrowded ports serving important North American markets. August saw a 34% rise in container volume via the Port compared to August 2020, while year-to-date tonnage saw a 27% increase. Part of that achievement may be attributed to a 37% rise in refrigerated containers as a result of the Port's almost $74 million investment in refrigerated facilities to serve cold cargo supply chains.
The market for temperature-controlled packaging solutions for pharmaceuticals is anticipated to rise as a result of expanding research and development initiatives around the world aimed at improving the manufacturing and packaging processes in the pharmaceutical and biotech industries. Along with pharmaceutical materials, the growing development of innovative medications and therapies such stem cells, r-proteins, and monoclonal antibodies has increased the demand for cold chain packaging systems at different phases of product development, driving market expansion. Therefore, such factors are enhanced the Temperature Controlled Packaging for Pharmaceutical market CAGR across the globe in the recent years.
However, to cater the demand there has been growth in chronic diseases patients. For instance, there has been a number of introductions of temperature controlled packaging for pharmaceutical is another factor driving the growth of the temperature controlled packaging for pharmaceutical market revenue.
The temperature controlled packaging for pharmaceutical market segmentation, based on product, includes insulated shippers, and insulated containers. The insulated shipper segment held the majority share in 2021 contribution to around ~58-65% in respect to the temperature controlled packaging for pharmaceutical market revenue. Applications across a wide range of industries, such as the pharmaceutical, food and beverage, and chemical sectors, are anticipated to increase shippers' convenience. As technology has advanced, there has been a continual rise in the demand for insulated shippers. For instance, the development of vacuum insulated panels (VIP) and phase change materials (PCMs) has allowed insulated shippers to provide a low-distribution temperature range. The delivery of pharmaceutical and therapeutic supplies has benefited greatly from these products.
Credo Cargo Pallet Shipper System, a reusable bulk shipper featuring cutting-edge slot-in components for simple loading and unloading, was introduced by Pelican Biothermal.
The temperature controlled packaging for pharmaceutical market segmentation, based on type, includes active systems and passive systems. The temperature controlled packaging for pharmaceutical market's active system segment is the largest by type. Active containers include active temperature control, which uses electric cooling or dry ice to keep the temperature inside the container within a set range. When compared to a passive system, the active system offers the maximum level of temperature accuracy. A costly alternative that offers a steady temperature for long-distance shipping is the active system. The supply chain delay can be effectively managed by the system. The presence of a power supply reduces the likelihood of temperature excursions. The active systems will be driven by the expanding transportation of bulk volume payload of medicinal items that require certain temperatures. Hence, the increasing number of shipping containers are anticipated to aids the market growth.
Based on End Users, the temperature controlled packaging for pharmaceutical market data has been segmented into pharmaceutical and clinical trails. Pharmaceutical accounts the largest segment share in 2021, owing to the growing demand for medicines throughout the world, and increasing number of chronic disease patients. Moreover, increasing government initiatives to improve the healthcare infrastructure, and the expansion of pharmaceutical industry is expected to bolster at a significant CAGR during the forecast period.
By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America temperature controlled packaging for pharmaceutical market accounted for USD 4.42 billion in 2021 and is expected to exhibit a significant CAGR of 43.80% growth during the study period. This is attributed to the growing incidence of chronic diseases, and increasing number of clinical trials, as well as an ageing population across the region.
Further, the major countries studied in the temperature controlled packaging for pharmaceutical market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Europe temperature controlled packaging for pharmaceutical market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an ageing population, and an increase in incidence of chronic disease, and osteoarthritis. Further, the Germany temperature controlled packaging for pharmaceutical market held the largest market share, and the UK temperature controlled packaging for pharmaceutical market was the fastest growing market in the European region
The Asia-Pacific temperature controlled packaging for pharmaceutical Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to increased population, rising spending on healthcare infrastructure, and others. Moreover, China temperature controlled packaging for pharmaceutical market held the largest market share, and the India temperature controlled packaging for pharmaceutical market was the fastest growing market in the Asia-Pacific region.
Major market players are spending a lot of money on R&D to increase their product lines, which will help the temperature controlled packaging for pharmaceutical market grow even more. Temperature controlled packaging for pharmaceutical market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as mergers and acquisitions, contractual agreements, increased investments, new product launches, and collaboration with other organizations. Competitors in the temperature controlled packaging for pharmaceutical industry must offer cost-effective items to expand and survive in an increasingly competitive and rising temperature controlled packaging for pharmaceutical market environment.
One of the primary business strategies adopted by manufacturers in the temperature-controlled packaging for pharmaceutical industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, temperature controlled packaging for pharmaceutical industry has provided medicine with some of the most significant benefits. The temperature controlled packaging for pharmaceutical market major player such as Softbox Systems (UK), FedEx Corporation (US), Sofrigam SA (France), Envirotainer AB (Sweden), DGP Intelsius GMBH (UK), and others are working to expand the market demand for temperature controlled packaging for pharmaceutical by investing in research and development activities.
Softbox Systems is engaged in manufacturing of thermal coverings and packaging systems with temperature controls for the life science sector. For the biotechnology and pharmaceutical industries, the company develops and manufactures high-performance passive temperature control packaging solutions. These solutions are intended to protect the quality of temperature-sensitive medicines, vaccines, and active pharmaceutical ingredients ("API") during distribution. For instance, in October 2022, the most comprehensive provider of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, CSafe, has introduced CSafeAPS, a new, high-tech reusable pallet shipper.
Also, FedEx offers business, e-commerce, and transportation services. FedEx Express, FedEx Ground, FedEx Freight, and FedEx Services make up its four operating segments. Deliveries of parcels and freight can be made using the shipping services provided by the FedEx Express division. The FedEx Ground sector provides money-back guaranteed ground package delivery services for commercial and residential customers, as well as consolidates and delivers. In August 2019, FedEx Express has introduced improved temperature-controlled shipping options that allow customers to pack their international shipments at their place of business. With the service, FedEx will provide two distinct packaging options. The va-Q-one is a highly sought-after service among customers in the healthcare industry and is for temperature ranges of minus 25°C to minus 15°C, 2°C to 8°C, and 15°C to 25°C. The box comes in five various sizes with a capacity ranging from 4 to 74 litres, and it uses coolants to maintain its temperature for 96 hours.
March 2021: By establishing new regional offices in the Netherlands, Cold Chain Technologies intended to increase the market for its temperature-controlled systems in the EMEA (Europe, the Middle East, and Africa) region.
November 2020: EOS line of parcel shippers was introduced by Sonoco Products Company. The product's temperature control packaging system is recyclable.
November 2020: For the purpose of distributing COVID-19 vaccinations, Cold Chain Technologies plans to construct a new plant in Lebanon, United States.
|Market Size 2021||USD 10.1 billion|
|Market Size 2022||USD 11.02 billion|
|Market Size 2030||USD 20.42 billion|
|Compound Annual Growth Rate (CAGR)||9.20% (2022-2030)|
|Market Forecast Period||2022-2030|
|Historical Data||2018 & 2020|
|Market Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Type, Temperature Range, End-Use Industry, and Region|
|Geographies Covered||North America, Europe, Asia Pacific, and Rest of the World|
|Countries Covered||The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil|
|Key Companies Profiled||Softbox Systems (UK), FedEx Corporation (US), Sofrigam SA (France), Envirotainer AB (Sweden), and DGP Intelsius GMBH (UK)|
|Key Market Opportunities||Rising spending on healthcare infrastructure in the developing countries|
|Key Market Dynamics||Rising prevalence of chronic diseases throughout the world Increasing geriatric population|
The temperature controlled packaging for pharmaceutical market size was valued at USD 10.1 Billion in 2021.
The market for temperature controlled packaging for pharmaceutical is projected to grow at a CAGR of 9.20% during the forecast period, 2022-2030.
North America had the largest share in the market for temperature controlled packaging for pharmaceutical.
The key players in the market for temperature controlled packaging for pharmaceutical are Softbox Systems (UK), FedEx Corporation (US), Sofrigam SA (France), Envirotainer AB (Sweden), and DGP Intelsius GMBH (UK).
The active systems type category dominated the market for temperature controlled packaging for pharmaceutical in 2021.
The pharmaceutical industry had the largest share in the market for temperature controlled packaging for pharmaceutical.
Key Questions Answered
Why Choose Market Research Future?